APA (7th ed.) Citation

Aguareles, J., Villares Fernández, P., Forné, C., Martí-Ballesteros, E. M., Pradillo Fernández, V., Sotres-Fernandez, G., . . . Guisado-Vasco, P. (2024). Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment. Infectious Diseases, 56(7), 575. https://doi.org/10.1080/23744235.2024.2351043

Chicago Style (17th ed.) Citation

Aguareles, Jose, et al. "Outcomes and Clinical Characteristics of the Compassionate Use of Plitidepsin in COVID-19 Patients with Solid Tumours, Haematological Malignancies or Anti-CD20 Antibody Treatment." Infectious Diseases 56, no. 7 (2024): 575. https://doi.org/10.1080/23744235.2024.2351043.

MLA (9th ed.) Citation

Aguareles, Jose, et al. "Outcomes and Clinical Characteristics of the Compassionate Use of Plitidepsin in COVID-19 Patients with Solid Tumours, Haematological Malignancies or Anti-CD20 Antibody Treatment." Infectious Diseases, vol. 56, no. 7, 2024, p. 575, https://doi.org/10.1080/23744235.2024.2351043.